fulvestrant has been researched along with Hypertension, Portal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Wu, ZY; Zhang, B; Zhang, CG; Zhou, QB | 1 |
| Hasimoto, O; Nakamura, T; Sakamoto, M; Sakata, R; Sata, M; Torimura, T; Ueno, T | 1 |
2 other study(ies) available for fulvestrant and Hypertension, Portal
| Article | Year |
|---|---|
Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
Topics: Animals; Antioxidants; Arterioles; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Fulvestrant; Hemodynamics; Hydrogen Peroxide; Hypertension, Portal; Ligation; Mesenteric Arteries; Ovariectomy; Oxidative Stress; Portal Pressure; Portal Vein; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Superoxides; Vascular Resistance | 2013 |
Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Topics: Animals; Cells, Cultured; Endothelial Cells; Estradiol; Estrogen Antagonists; Fulvestrant; Hypertension, Portal; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Portal Pressure; Rats; Rats, Sprague-Dawley | 2005 |